MarketPulse

drug safety

7 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Soleno Therapeutics Faces Class Action Over Safety Risks in Lead Drug DCCR

Portnoy Law Firm launches class action lawsuit against $SLNO alleging concealment of safety issues in lead drug DCCR, following 27% stock plunge.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno Therapeutics Faces Securities Class Action Over VYKAT XR Safety Disclosures

Hagens Berman files securities class action against $SLNO alleging concealed safety risks and inflated metrics for hyperphagia drug VYKAT XR. Stock crashed 27% following August activist report and November earnings miss.
SLNOinvestor lossessecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Glancy Prongay Wolke & Rotter Llp

Soleno Therapeutics Faces Securities Fraud Lawsuit Over DCCR Drug Disclosures

Class action lawsuit filed against $SLNO for allegedly concealing safety concerns and patient death related to experimental drug DCCR, causing significant shareholder losses.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Soleno Therapeutics Faces Class Action Over Concealed Safety Data in Lead Drug Candidate

Portnoy Law Firm sues Soleno Therapeutics for allegedly concealing DCCR safety risks in Phase 3 trials, citing 27% stock drop on November 4, 2025.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Soleno Therapeutics Hit with Securities Fraud Lawsuit Over Hidden Drug Safety Risks

Soleno Therapeutics faces class action lawsuit for allegedly concealing drug safety risks including fluid retention and diabetes complications. Affected shareholders can claim losses through May 2026.
SLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Grabar Law Office

Four Companies Face Securities Fraud Investigations Over Material Disclosures

Grabar Law Office investigates securities fraud claims against $ASPI, $CWH, $EOSE, and $SLNO for alleged disclosure failures. Long-term shareholders may seek compensation and reforms at no cost.
CWHEOSEASPISLNOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno Therapeutics Hit With Class Action Over VYKAT Launch Failures and Safety Disclosures

$SLNO faces securities lawsuit alleging misleading safety claims for hyperphagia drug VYKAT XR. Stock crashed 40% after short seller report and management admissions of launch disruptions.
SLNOsecurities class actionclinical trial